Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana


The primary objective of the study is to evaluate changes in the expression of targeted biomarkers in invasive breast cancer tissue before and after SNDX-275 administration.


Inclusion criteria: - Is scheduled for breast biopsy due to a suspicious mass palpable or ≥1 cm on mammogram - Must be able to receive two doses of study medication 7 days apart prior to surgery - Has histologically confirmed invasive breast cancer with ER positive, ER and/or PR negative histology or triple negative (for ER, PR, HER-2) histology - Has an ECOG performance status ≤ 2 - Has no clinically significant laboratory or cardiac abnormalities - Has a negative serum pregnancy test at Screening as is either post menopausal, sterile or willing to use an approved method of contraception. - Is able to swallow and retain oral medication Exclusion criteria: - Has a concomitant medical condition that precludes adequate study treatment compliance or assessment, such as: a. Bleeding disorders that would increase risks of additional core biopsy for biomarkers b. Morbid obesity - Is currently receiving treatment with a medication on the prohibited medication list - Has allergy to benzamides or inactive components of study drug - Is participating in another clinical trial or has received another investigational agent within 30 days prior to informed consent



Primary Contact:

Principal Investigator
Monet Bowling, MD
Indiana University

Backup Contact:


Location Contact:

Indianapolis, Indiana
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.